444 related articles for article (PubMed ID: 27595760)
61. Disease-oriented treatment of T-cell lymphoma.
Makita S; Tobinai K
Hematol Oncol; 2017 Jun; 35 Suppl 1():54-59. PubMed ID: 28591416
[No Abstract] [Full Text] [Related]
62. Nasal-type NK/T-cell lymphoma presenting as hemophagocytic syndrome in an 11-year-old Mexican boy.
Brodkin DE; Hobohm DW; Nigam R
J Pediatr Hematol Oncol; 2008 Dec; 30(12):938-40. PubMed ID: 19131786
[TBL] [Abstract][Full Text] [Related]
63. A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome.
Tan B; Abdelmalek C; O'Donnell JE; Toltaku T; Chaudhry R; Wang JC; Gotlieb V
Am J Case Rep; 2017 Feb; 18():160-165. PubMed ID: 28193996
[TBL] [Abstract][Full Text] [Related]
64. A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.
Hong H; Huang H; Fang X; Wang Z; Ye S; Zhang H; Huang Y; Guo H; Chen X; Liang C; Pu X; Cao Y; Lin S; Li X; Ren Q; Liu Q; Lin T
Am J Hematol; 2019 May; 94(5):E122-E124. PubMed ID: 30690754
[No Abstract] [Full Text] [Related]
65. The clinical study of extranodal natural killer cell lymphoma, nasal type.
Gui W; Zhao Z; Shen Q; Wang T; Yang B; He J; Li X; Hou S; Zhang L; Zhang Q; Su L
Med Oncol; 2011 Dec; 28 Suppl 1():S367-72. PubMed ID: 21128014
[TBL] [Abstract][Full Text] [Related]
66. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
67. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
68. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
69. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
[TBL] [Abstract][Full Text] [Related]
70. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
[TBL] [Abstract][Full Text] [Related]
71. Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
Hanakawa H; Orita Y; Sato Y; Takao S; Marunaka H; Morishita T; Yamashita Y; Hori Y; Domae S; Inokuchi I; Akagi S; Kondo E; Iwaki N; Motomiya K; Okumura H; Yoshino T; Nishizaki K
Head Neck; 2014 Apr; 36(4):551-6. PubMed ID: 23780926
[TBL] [Abstract][Full Text] [Related]
72. Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States.
Kommalapati A; Tella SH; Ganti AK; Armitage JO
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):475-479. PubMed ID: 29752210
[TBL] [Abstract][Full Text] [Related]
73. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
74. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
[TBL] [Abstract][Full Text] [Related]
75. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability.
Kim SM; Park S; Oh DR; Ahn YC; Ko YH; Kim SJ; Kim WS
Ann Hematol; 2016 Mar; 95(4):581-91. PubMed ID: 26729202
[TBL] [Abstract][Full Text] [Related]
76. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
[TBL] [Abstract][Full Text] [Related]
77. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
78. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
[TBL] [Abstract][Full Text] [Related]
79. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution.
Yu JT; Wang CY; Yang Y; Wang RC; Chang KH; Hwang WL; Teng CL
Ann Hematol; 2013 Nov; 92(11):1529-36. PubMed ID: 23700280
[TBL] [Abstract][Full Text] [Related]
80. Profiling and bioinformatics analyses reveal differential circular RNA expression in NK/T-cell lymphoma-associated hemophagocytic syndrome.
Man C; Fan Y; Yin G; Huang J; Wang J; Qiu H
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32856037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]